Siglinde Wolf
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Organic Chemistry top 5%
- Click Chemistry and Applications
- Multicomponent Synthesis of Heterocycles
- Synthesis and biological activity
Papers in
-
- Chemical Synthesis and Analysis 6
- Oncology 7
- Cancer-related Molecular Pathways 7
- Co-authors
- Tad A. Holak (11 shared papers)Grzegorz M. Popowicz (8 shared papers)Alexander Dömlingꝉ (10 shared papers)Anna Czarna (4 shared papers)Wei Wang (3 shared papers)Yijun Huang (5 shared papers)Michał Biśta (5 shared papers)Kan Wang (1 shared paper)
- Journals
- Cell Cycle (2 papers)ACS Combinatorial Science (1 paper)ChemMedChem (1 paper)Angewandte Chemie International Edition (1 paper)Bioorganic & Medicinal Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Siglinde Wolf
11 papers receiving 687 citations
Peers
Comparison fields: 5 of 48
- Oncology 303
- Organic Chemistry 326
- Molecular Biology 476
- Biotechnology 46
- Computational Theory and Mathematics 84
Countries citing papers authored by Siglinde Wolf
This map shows the geographic impact of Siglinde Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siglinde Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siglinde Wolf more than expected).
Fields of papers citing papers by Siglinde Wolf
This network shows the impact of papers produced by Siglinde Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siglinde Wolf. The network helps show where Siglinde Wolf may publish in the future.
Co-authors
The 22 scholars most cited alongside Siglinde Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 189 | |
| 2 | 2010 | 113 | |
| 3 | 2009 | 88 | |
| 4 | 2012 | 79 | |
| 5 | 2010 | 50 | |
| 6 | 2013 | 47 | |
| 7 | 2011 | 41 | |
| 8 | 2014 | 34 | |
| 9 | 2010 | 21 | |
| 10 | 2012 | 17 | |
| 11 | 2014 | 12 |
About Siglinde Wolf
Siglinde Wolf is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Virology, having authored 11 papers that have together received 691 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Chemical Synthesis and Analysis (6 papers), Click Chemistry and Applications (5 papers), HIV Research and Treatment (3 papers), Microbial Natural Products and Biosynthesis (3 papers), Cancer Research and Treatments (1 paper), HIV/AIDS drug development and treatment (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Oncology (303 citations), Organic Chemistry (326 citations), Molecular Biology (476 citations), Biotechnology (46 citations) and Computational Theory and Mathematics (84 citations). Siglinde Wolf has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Tad A. Holak, Grzegorz M. Popowicz, Alexander Dömlingꝉ, Anna Czarna, Wei Wang, Yijun Huang, Michał Biśta, Kan Wang, Carlos J. Camacho and Barbara Beck. Their work appears in journals such as Cell Cycle, ACS Combinatorial Science, ChemMedChem, Angewandte Chemie International Edition and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.